LabCorp is Scheduled to Present at the Cowen and Company 27th Annual Health Care Conference



    BURLINGTON, N.C., March 12 /CNW/ -- Laboratory Corporation of America(R)
Holdings (LabCorp(R)) (NYSE:   LH) today announced that David P. King, Chief
Executive Officer, William B. (Brad) Hayes, Executive Vice President and Chief
Financial Officer, and Bradford T. Smith, Executive Vice President, Corporate
Affairs, are scheduled to speak at the Cowen and Company 27th Annual Health
Care Conference in Boston, MA.  LabCorp's presentation is planned for Tuesday,
March 13, 2007 at 4:00 p.m. (Eastern Time).
    A live audio webcast of the presentation will be available via the
Company Web site at www.labcorp.com and archived for replay.

    
    About LabCorp
    
    Laboratory Corporation of America(R) Holdings, a S&P 500 company, is a
pioneer in commercializing new diagnostic technologies and the first in its
industry to embrace genomic testing.  With annual revenues of $3.6 billion in
2006, over 25,000 employees nationwide, and more than 220,000 clients, LabCorp
offers clinical assays ranging from routine blood analyses to HIV and genomic
testing. LabCorp combines its expertise in innovative clinical testing
technology with its Centers of Excellence: The Center for Molecular Biology
and Pathology, in Research Triangle Park, NC; National Genetics Institute,
Inc. in Los Angeles, CA; ViroMed Laboratories, Inc. based in Minneapolis, MN;
The Center for Esoteric Testing in Burlington, NC; DIANON Systems, Inc. based
in Stratford, CT; US LABS based in Irvine, CA; and Esoterix and its Colorado
Coagulation, Endocrine Sciences, and Cytometry Associates laboratories. 
LabCorp clients include physicians, government agencies, managed care
organizations, hospitals, clinical labs, and pharmaceutical companies. To
learn more about our growing organization, visit our Web site at:
www.LabCorp.com.

    Each of the above forward-looking statements is subject to change based
on various important factors, including without limitation, competitive
actions in the marketplace and adverse actions of governmental and other
third-party payors.  Actual results could differ materially from those
suggested by these forward-looking statements. Further information on
potential factors that could affect LabCorp's financial results is included in
the Company's Form 10-K for the year ended December 31, 2006, and subsequent
SEC filings.





For further information:

For further information: Investors, Scott Fleming, +1-336-436-4879, or 
Media, Pam Sherry, +1-336-436-4855, both of LabCorp; or Shareholder Direct, 
+1-800-LAB-0401 Web Site: http://www.labcorp.com

Organization Profile

LABORATORY CORPORATION OF AMERICA HOLDINGS

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890